nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Adoptive immunotherapy: Engineering T cell responses as biologic weapons for tumor mass destruction
|
Ho, William Y |
|
2003 |
3 |
5 |
p. 431-437 7 p. |
artikel |
2 |
Altered receptor trafficking in Huntingtin Interacting Protein 1-transformed cells
|
Rao, Dinesh S. |
|
2003 |
3 |
5 |
p. 471-482 12 p. |
artikel |
3 |
A peptide trivalent arsenical inhibits tumor angiogenesis by perturbing mitochondrial function in angiogenic endothelial cells
|
Don, Anthony S |
|
2003 |
3 |
5 |
p. 497-509 13 p. |
artikel |
4 |
Cell fusion: A hidden enemy?
|
Duelli, Dominik |
|
2003 |
3 |
5 |
p. 445-448 4 p. |
artikel |
5 |
Chk1 and Chk2 kinases in checkpoint control and cancer
|
Bartek, Jiri |
|
2003 |
3 |
5 |
p. 421-429 9 p. |
artikel |
6 |
Engineering de novo reciprocal chromosomal translocations associated with Mll to replicate primary events of human cancer
|
Forster, Alan |
|
2003 |
3 |
5 |
p. 449-458 10 p. |
artikel |
7 |
FANCF methylation contributes to chemoselectivity in ovarian cancer
|
Olopade, Olufunmilayo I |
|
2003 |
3 |
5 |
p. 417-420 4 p. |
artikel |
8 |
Human mammary epithelial cell transformation through the activation of phosphatidylinositol 3-kinase
|
Zhao, Jean J |
|
2003 |
3 |
5 |
p. 483-495 13 p. |
artikel |
9 |
PDGF receptors as cancer drug targets
|
Pietras, Kristian |
|
2003 |
3 |
5 |
p. 439-443 5 p. |
artikel |
10 |
PKC412 overcomes resistance to imatinib in a murine model of FIP1L1-PDGFRα-induced myeloproliferative disease
|
Cools, Jan |
|
2003 |
3 |
5 |
p. 459-469 11 p. |
artikel |
11 |
Targeting oncogene dependence and resistance
|
Hingorani, Sunil R |
|
2003 |
3 |
5 |
p. 414-417 4 p. |
artikel |
12 |
Transgenics at breaking-point
|
Prosser, Haydn |
|
2003 |
3 |
5 |
p. 411-413 3 p. |
artikel |